CA2126236A1 - Peptide compounds having therapeutic activity - Google Patents

Peptide compounds having therapeutic activity

Info

Publication number
CA2126236A1
CA2126236A1 CA002126236A CA2126236A CA2126236A1 CA 2126236 A1 CA2126236 A1 CA 2126236A1 CA 002126236 A CA002126236 A CA 002126236A CA 2126236 A CA2126236 A CA 2126236A CA 2126236 A1 CA2126236 A1 CA 2126236A1
Authority
CA
Canada
Prior art keywords
ahx
trp
gly
hpa
mephe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002126236A
Other languages
English (en)
French (fr)
Inventor
Myles Edward Pierson
James Donald Rosamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929220543A external-priority patent/GB9220543D0/en
Priority claimed from GB929220761A external-priority patent/GB9220761D0/en
Application filed by Individual filed Critical Individual
Publication of CA2126236A1 publication Critical patent/CA2126236A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C07K14/5955—Gastrins; Cholecystokinins [CCK] at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002126236A 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity Abandoned CA2126236A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US81098591A 1991-12-20 1991-12-20
US07/810,985 1991-12-20
GB929220543A GB9220543D0 (en) 1992-09-29 1992-09-29 Pharmacologically active compounds
GB929220761A GB9220761D0 (en) 1992-10-02 1992-10-02 Pharmaceutically active compounds
GB9220543.4 1992-10-02
GB9220761.2 1992-10-02

Publications (1)

Publication Number Publication Date
CA2126236A1 true CA2126236A1 (en) 1993-07-08

Family

ID=27266393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002126236A Abandoned CA2126236A1 (en) 1991-12-20 1992-12-21 Peptide compounds having therapeutic activity

Country Status (11)

Country Link
EP (1) EP0619823A1 (enExample)
JP (1) JPH08500324A (enExample)
AU (1) AU672186B2 (enExample)
CA (1) CA2126236A1 (enExample)
FI (1) FI942898A0 (enExample)
HU (1) HU211564A9 (enExample)
IL (1) IL104161A0 (enExample)
MX (1) MX9207458A (enExample)
NO (1) NO942350L (enExample)
NZ (1) NZ246195A (enExample)
WO (1) WO1993013126A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7762610B2 (ja) * 2022-03-28 2025-10-30 雪印メグミルク株式会社 アンジオテンシン変換酵素阻害ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754248R (fr) * 1969-08-01 1971-02-01 Farmaceutici Italia Polypeptides a activite
NZ218607A (en) * 1985-12-19 1989-10-27 Pennwalt Corp Tri-to acta-peptides with sulphate ester groups: obesity treatment
IL84478A0 (en) * 1986-11-18 1988-04-29 Pennwalt Corp Peptides with sulfate ester groups and their preparation
DE69017704T2 (de) * 1989-11-27 1995-07-20 Fisons Corp Hexapeptide mit sulphat-ester-gruppen.

Also Published As

Publication number Publication date
FI942898L (fi) 1994-06-17
AU3167893A (en) 1993-07-28
NZ246195A (en) 1995-11-27
IL104161A0 (en) 1993-05-13
NO942350D0 (enExample) 1994-06-20
WO1993013126A1 (en) 1993-07-08
FI942898A7 (fi) 1994-06-17
AU672186B2 (en) 1996-09-26
FI942898A0 (fi) 1994-06-17
JPH08500324A (ja) 1996-01-16
HU211564A9 (en) 1995-12-28
MX9207458A (es) 1993-11-01
NO942350L (no) 1994-06-20
EP0619823A1 (en) 1994-10-19

Similar Documents

Publication Publication Date Title
US4737487A (en) VIP type peptides
IL154575A (en) Ring peptides, process for their preparation and use in the preparation of a drug for the treatment of diseases associated with the activity of R-4 MC
RU2361876C2 (ru) Пептидные векторы
JP2569316B2 (ja) 硫酸エステル基を有するペプチド
HU185321B (en) Process for preparing pharmacologically active ancephaline analogues
US5086042A (en) Peptides with sulfate ester groups
US4133805A (en) Cyclic undecapeptides related to somatostatin and intermediates therefor
EP0268297A2 (en) Peptides with sulfate ester groups
CA2126236A1 (en) Peptide compounds having therapeutic activity
Pawlak et al. Synthesis of a novel side‐chain to side‐chain cyclized enkephalin analogue containing a carbonyl bridge
US4102878A (en) Process for the preparation of the cholecystokinin-pancreozymin octapeptide amide sulfate ester
US5502164A (en) Peptide compounds having therapeutic activity
AU644128B2 (en) Hexapeptides with sulphate ester groups
US4105652A (en) Synthesis of human β-endorphin
SE464814B (sv) Gonadoliberinderivat innehaallande en beta-aspartylgrupp, ett foerfarande foer framstaellning daerav och farmaceutiska preparat innehaallande desamma
HU201338B (en) Process for producing peptides and pharmaceutical compositions containing them
EP1668027B1 (en) Cyclic peptides acting as urotensin-ii antagonists
GB2118190A (en) Peptides with sauvagine-like activity
JPS63198699A (ja) スルフエートエステル基を有するペプチド
JPS6330499A (ja) オピオイドペプチド・ポリペプチド複合体

Legal Events

Date Code Title Description
FZDE Discontinued